| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.73B | $2.56B | $2.41B |
| YoY Revenue Growth % | +6.3% | +6.2% | — |
| Gross Profit | $2.36B | $2.25B | — |
| Gross Margin % | 86.7% | 87.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $831.1M | $876.0M | $899.1M |
| Operating Margin % | 30.5% | 34.2% | 37.2% |
| Net Income (GAAP) | $1.06B | $845.7M | $840.3M |
| EBITDA (Normalized) | $852.4M | $895.4M | $986.0M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.20B | $1.05B | $1.04B |
| Capital Expenditures (CapEx) | $26.6M | $24.2M | $108.7M |
| Free Cash Flow (FCF) | $1.17B | $1.03B | $929.2M |
| FCF Margin % | 43.0% | 40.1% | 38.5% |
| Return on Invested Capital (ROIC %) | 19.9% | 19.1% | 13.6% |
| Cash & Short-Term Equivalents | $1.80B | $506.2M | — |
| Total Debt (Short + Long Term) | $2.22B | $1.33B | $2.02B |
| Total Stockholders' Equity | $2.88B | $2.79B | $4.14B |